Modulation of macrophage and B cell function by glycosaminoglycans

Journal of Leukocyte Biology

Volumn 66, Issue 3, 1999, Pages 391-400

  Wrenshall, Lucile E ^a,c   Stevens, R Brian ^a   Cerra, Frank B ^a   Platt, Jeffrey L ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c Box 356174 ^*  (United States)

Author keywords

Cytokines; Heparan sulfate; Macrophages

Indexed keywords

CHONDROITIN SULFATE; DERMATAN SULFATE; GAMMA INTERFERON; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032869736     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.66.3.391     Document Type: Article

References (57)

1. Gallin, J. I. (1989) Fundamental immunology. In Inflammation (W. Paul, ed.), New York: Raven Press.
2. Sherman, L., Sleeman, J., Herrlich, P., Ponta, H. (1994) Hyaluronate receptors: key players in growth, differentiation, migration, and tumor regression. Curr. Opin. Cell. Biol. 6, 726-733.
3. Knudson, C. B., Toole, B. P. (1987) Hyaluronate-cell interactions during chick differentiation of chick embryo limb mesoderm. Dev. Biol. 124, 82-90.
4. Comper, W. D., Laurent, T. C. (1978) Physiological function of connective tissue polysaccharides. Physiol. Rev. 58, 255-315.
5. Miyake, K., Medina, K. L., Hayashi, S., Ono, S., Hamaoka, T., Kincade, P. W. (1990) Monoclonal antibodies to Pgp-1/CD44 block lympho-hematopoiesis in long-term bone marrow cultures. J. Exp. Med. 171, 477-488.
6. Shimizu, Y., Shaw, S. (1991) Lymphocyte interactions with extracellular matrix. FASEB J. 5, 2292-2299.
7. Thorens, B., Mermod, J., Vassalli, P. (1987) Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulation. Cell 48, 671-679.
8. Geller, R. L., Ihrcke, N. S., Maines, J., Lindman, B. J., Platt, J. L. (1993) Loss of heparan sulfate proteoglycans as a manifestation of cellular immunity in vivo and in vitro. Transplant. Proc. 25, 144-145.
9. Key, N. S., Platt, J. L., Vercellotti, G. M. (1992) Vascular endothelial cell proteoglycans are susceptible to cleavage by neutrophils. Arterio. Thromb. 12, 836-842.
10. Wrenshall, L. E., Cerra, F. B., Carlson, A., Bach, F. B., Platt, J. L. (1991) Regulation of murine splenocyte responses by heparan sulfate. J. Immunol. 147, 455-459.
11. Wrenshall, L. E., Carlson, A., Cerra, F. B., Platt, J. L. (1994) Modulation of cytolytic T cell responses by heparan sulfate. Transplantation 57, 1087-1094.
12. Wrenshall, L E., Cerra, F. B., Singh, R. K., Platt, J. L. (1995) Heparan sulfate initiates signals in murine macrophages leading to divergent biological outcomes. J. Immunol. 154, 871-880.
13. Yokoi, Y., Nakamura, S., Muro, H., Bba, S. (1994) Functional abnormalities of sinusoidal endothelial cells in rats with acute liver rejection. Transplantation 57, 27-31.
14. Weber, S., Kruger-Krasagakes S., Grabbe, J., Zuberbier, T., Czarnetski, B. (1995) Mast cells. Int. J. Dermatol. 34, 1-10.
15. Gao, G., Goldfarb, M. (1995) Heparin can activate a receptor tyrosine kinase. EMBO J. 14, 2183-2190.
16. Entwistle, J., Hall, C., Turley, E. (1996) HA receptors: regulators of signaling to the cytoskeleton. J. Cell. Biochem. 61, 569-577.
17. Aarden, L. A., DeGroot, E. R., Schaap, O. L., Lansdorf, P. (1987) Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 17, 1411-1416.
18. Kaye, J., Gillis, S., Mizel, S. B., Shevach, E. M., Malek, T. R., Dinarello, C. A., Lachman, L. B., Janeway, C. A. (1984) Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors of interleukin 2. J. Immunol. 133, 1339-1345.
19. Hibbs, J. B., Jr., Taintor, R. R., Vavrin, Z., Rachlin, E. M. (1988) Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157, 87-94.
20. Mochizuki, M., Zigler, J. S., Russell, P., Gery, I. (1984) Cytostatic and cytolytic activities of macrophages regulation by prostaglandins. Cell. Immunol. 83, 34-42.
21. Chomczynski, P., Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
22. Noble, P., Lake, F., Henson, P., Riches, D. (1993) Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-α-dependent mechanism in murine macrophages. J. Clin. Invest. 91, 2368-2377.
23. + T cells. J. Exp. Med. 185, 461-469.
24. Manetti,. R., Barak, V., Piccinni, M. P., Sampognaro, S., Parronchi, P., Maggi, E., Dinarello, C. A., Romagnani, S. (1994) Interleukin-1 favours the in vitro development of type 2 T helper (Th2) human T-cell clones. Res. Immunol. 145, 93-100.
25. Scott, W. A., Pawlowski, N. A., Murray, H. W., Andreach, M., Zrike, J., Cohn, Z. A. (1982) Regulation of arachidonic acid metabolism by macrophage activation. J. Exp. Med. 155, 1148-1160.
26. 2 is a potent inhibitor of human interleukin 12 production. J. Exp. Med. 181, 775-779.
27. Kolb, H., Kolb-Bachofen, V. (1992) Nitric oxide: a pathogenetic factor in autoimmunity. Immunol. Today 13, 157-160.
28. Decker, T., Lohmann-Matthes, M., Gifford, G. E. (1987) Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages. J. Immunol. 138, 957-962.
29. Onozaki, K., Matsushima, K., Aggarwal, B. B., Oppenheim, J. J. (1985a) Human interleukin 1 is a cytocidal factor for several tumor cell lines. J. Immunol. 135, 3962-3968.
30. Onozaki, K., Matsushima, K., Kleinerman, E. S., Saito, T., Oppenheim, J. J. (1985b) Role of interleukin 1 in promoting monocyte-mediated tumor cytotoxicity. J. Immunol. 135, 314-320.
31. Klostergaard, J., Leroux, E., Hung, M. (1991) Cellular models of macrophage tumoricidal effector mechanisms in vitro. J. Immunol. 147, 2802-2808.
32. Drysdale, B., Agarwal, S., Shin, H. S. (1988) Macrophage-mediated tumoricidal activity: mechanisms of activation and cytotoxicity. Prog. Allergy 41, 111-161.
33. Ihrcke, N. S., Platt, J. L. (1996) Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules. J. Cell Physiol. 166, 625-637.
34. Fridman, R., Naparstek, Y., Fuks, Z., Vlodavsky, I., Cohen, I. R. (1987) Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix. J. Cell Physiol. 130, 85-92.
35. Vilar, R., Ghael, D., Li, M., Bhagat, D., Arrigo, L., Cowman, M., Dweck, H., Rosenfeld, L. (1997) Nitric oxide degradation of heparin and heparan sulphate. Biochem. J. 324, 473-482.
36. Shimada, K., Ozawa, T. (1987) Subendothelial extracellular-matrix heparan sulfate proteoglycan degrading activity of human monocyte macrophages. Heart Vessels 3, 175-181.
37. Gallagher, J. T., Walker, A., Lyon, M., Evans, W. H. (1988) Heparan sulphate-degrading endoglycosidase in liver plasma membranes. Biochem. J. 250, 719-726.
38. Naparstek, Y., Cohen, I. R., Fuks, Z., Vlodavsky, I. (1984) Activated T lymphocytes produce a matrix-degrading heparan sulfate endoglycosidase. Nature 310, 241-244.
39. Platt, J. L., Vercelotti, G. M., Oegema, T. R., Bach, F. H., Dalmasso, A. P. (1984) Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection. J. Exp. Med. 171, 1363-1368.
40. Stevens, R. B., Wang, Y. L., Kaji, H., Lloveras, J., Dalmasso, A., Bach, F. H., Rubinstein, P., Sutherland, D. E., Platt, J. L. (1993) Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival. Transplant. Proc. 25, 382.
41. Alexander, C. M., Werb, Z. (1991) Extracellular matrix degradation. In Cell Biology of Extracellular Matrix (E. Hay, ed.), New York: Plenum, 255.
42. Werb, Z. (1989) Proteinases and matrix degradation. In Textbook of Rheumatology, 3rd ed. (W. N. Kelley, E. D. Harris, Jr., S. Ruddy, C. B. Sledge, eds.), Philadelphia: Saunders, 300.
43. Lohmander, L. S., Dahlberg, L., Ryd, L., Heinegard, D. (1989) Increased levels of proteoglycan fragments in knee joint fluid after injury. Arthritis Rheum. 32, 1434.
44. Saxne, T., Heinegard, D., Wollheim, F. A., Pettersson, H. (1985) Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis. Lancet 2, 127-128.
45. Fong, K., Boey, M., Koh, W., Feng, P. (1994) Cytokine concentrations in the synovial fluid and plasma of rheumatoid arthritis patients: correlation with bony erosions. Clin. Exp. Rheum. 12, 55-58.
46. Goetzl, E. J., Banda, M. J., Leppert, D. (1996) Matrix metalloproteases in immunity. J. Immunol. 156, 1-4.
47. Yaron, I., Meyer, F. A., Dayer, J., Yaron, M. (1987) Human recombinant interleukin-1β stimulates glycosaminoglycan production in human synovial fibroblast cultures. Arthritis Rheum. 30, 424-430.
48. Bartold, P. M., Haynes, D. R., Vernon-Roberts, B. (1989) Effect of mitogen and lymphokine stimulation on proteoglycan synthesis by lymphocytes. J. Cell. Physiol. 140, 82-90.
49. Bassols, A., Massague, J. (1989) Transforming growth factor β regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J. Biol. Chem. 263, 3039-3045.
50. Rasmussen, S., Rapraeger, A. (1989) Altered structure of the hybrid cell surface proteoglycan of mammary epithelial cells in response to transforming growth factor β. J. Biol. Chem. 107, 1959-1967.
51. Price, F., Levick, J. R., Mason, R. M. (1996) Glycosaminoglycan concentration in synovium and other tissues of rabbit knee in relation to synovial hydraulic resistance. J. Physiol. [Lond.] 15, 803-820.
52. Wrenshall, L. E., Cerra, F. B., Rubinstein, P., Platt, J. L. (1993) Regulation by heparan sulfate and IL-1α of the ontogenic expression of TcR, CD4, and CD8. Human Immunol. 38, 165-171.
53. Klein, D. J., Brown, D. M., Moran, A., Platt, J. L. (1989) Chondroitin sulfate proteoglycan synthesis and re-utilization of beta-D-xyloside-initiated chondroitin/dermatan sulfate glycosaminoglycans in fetal kidney branching morphogenesis. Dev. Biol. 133, 515-528.
54. Doherty, P. (1995) Anatomical environment as a determinant in viral immunity. J. Immunol. 155, 1023-1027.
55. Cantor, H. M., Dumont, A. E. (1967) Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 215, 744-745.
56. Daynes, R., Araneo, B., Dowell, T., Huang, K., Dudley, D. (1990) Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper function. J. Exp. Med. 171, 979-996.
57. Puddu, P., Fantuzzi, L., Borghi, P., Varano, B., Rainaldi, G., Guillemard, E., Malorni, W., Nicaise, P., Wolf, S., Belardelli, F., Gessani, S. (1997) IL-12 induces IFN-γ expression and secretion in mouse peritoneal macrophages. J. Immunol. 159, 3490-3497.